{"id":52115,"date":"2022-12-19T12:02:15","date_gmt":"2022-12-19T11:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/"},"modified":"2022-12-19T12:02:15","modified_gmt":"2022-12-19T11:02:15","slug":"regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/","title":{"rendered":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5699683\/regenerative-medicine-in-pharma-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=ps3hgj&amp;utm_campaign=1791793+-+Regenerative+Medicine+in+Pharma+Market+to+Grow+by+11.1%25++Annually+Through+2027+&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during 2022-2027. The Regenerative Medicine in Pharma market report provides an executive-level overview of the regenerative medicine market worldwide today, with detailed forecasts of key indicators up to 2027.\n<\/p>\n<p>\nThis market intelligence report offers a thorough, forward-looking analysis of the Regenerative Medicine in Pharma market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.\n<\/p>\n<p>\nThe regenerative medicine in pharma market size was valued at US$29.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during the forecast period (2022-2027). The market is driven by the growing prevalence of chronic diseases, genetic disorders, and cancer and technological advancements in stem-cell therapies.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nOverview of regenerative medicine in pharma market including industry trends, funding &amp; deals, pipeline analysis, regulatory details, and product &amp; company profile\n<\/li>\n<li>\nRegenerative medicine in pharma market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, technology, application, and geographic segments.\n<\/li>\n<li>\nRegenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.\n<\/li>\n<li>\nRegenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the route of administration segment.\n<\/li>\n<li>\nThe competitive landscape: an examination of the positioning of leading players in regenerative medicine in pharma market.\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nThis market intelligence report offers a thorough, forward-looking analysis of the Regenerative Medicine in Pharma market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.\n<\/li>\n<li>\nAccompanying the publisher&#8217;s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in regenerative medicine in pharma markets.\n<\/li>\n<li>\nThe report also highlights key product, therapeutic area segments.\n<\/li>\n<li>\nWith different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.\n<\/li>\n<li>\nThe report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in regenerative medicine in pharma market.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 01 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 02 Market Landscape<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 03 Regenerative Medicine in Pharma Value Chain<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 04 Regulatory and Market Access<\/strong>\n<\/p>\n<p>\n4.1 Differences Between Conventional Therapies and Stem Cell Therapies in Clinical Trials\n<\/p>\n<p>\n4.2 US\n<\/p>\n<p>\n4.2.1 Regulatory\n<\/p>\n<p>\n4.2.2 Market Access\n<\/p>\n<p>\n4.3 Europe\n<\/p>\n<p>\n4.4 Regulation of Regenerative Medicine in the US and Europe\n<\/p>\n<p>\n4.5 Japan\n<\/p>\n<p>\n4.6 South Korea\n<\/p>\n<p>\n<strong>CHAPTER 05 Marketed Products<\/strong>\n<\/p>\n<p>\n5.1 Overview\n<\/p>\n<p>\n5.1.1 Leading Cell-Based Immunotherapy Treatments\n<\/p>\n<p>\n5.1.2 Leading Gene Therapy Treatments\n<\/p>\n<p>\n5.1.3 Leading Cell-Therapies Treatment\n<\/p>\n<p>\n5.1.4 Leading Tissue Engineered Products Treatments\n<\/p>\n<p>\n<strong>CHAPTER 06 Regenerative Medicine Pipeline Products in the 8MM<\/strong>\n<\/p>\n<p>\n6.1 Late-Stage Gene Therapy Products\n<\/p>\n<p>\n6.2 Late-Stage Gene-Modified Cell Therapy Products\n<\/p>\n<p>\n6.3 Late-Stage Cell Therapy Products\n<\/p>\n<p>\n6.4 Late-Stage Tissue-Engineered Treatment\n<\/p>\n<p>\n<strong>CHAPTER 07 Regenerative Medicine in Pharma Industry Analysis<\/strong>\n<\/p>\n<p>\n7.1 Regenerative Medicine in Pharma Market Structure &#8211; PORTER&#8217;s Analysis\n<\/p>\n<p>\n7.2 Deals in Regenerative Medicine in Pharma\n<\/p>\n<p>\n7.3 Funding in Regenerative Medicine in Pharma\n<\/p>\n<p>\n<strong>CHAPTER 08 Global Regenerative Medicine in Pharma Revenue Opportunity<\/strong>\n<\/p>\n<p>\n8.1 Global Digital Biomarkers Market\n<\/p>\n<p>\n8.2 COVID-19 Pandemic\n<\/p>\n<p>\n<strong>CHAPTER 09 Regenerative Medicine in Pharma Product Outlook<\/strong>\n<\/p>\n<p>\n9.1 Regenerative Medicine in Pharma &#8211; Product Dive\n<\/p>\n<p>\n9.1.1 Tissue-Engineered Products\n<\/p>\n<p>\n9.1.2 Gene Therapies\n<\/p>\n<p>\n9.1.3 Cell Therapies\n<\/p>\n<p>\n9.1.4 Others\n<\/p>\n<p>\n<strong>CHAPTER 010 Regenerative Medicine in Pharma Therapeutic Area Outlook<\/strong>\n<\/p>\n<p>\n10.1 Regenerative Medicine in Pharma &#8211; Therapeutic Area Dive\n<\/p>\n<p>\n<strong>CHAPTER 011 Regenerative Medicine in Pharma Regional Outlook<\/strong>\n<\/p>\n<p>\n11.1 Regenerative Medicine in Pharma &#8211; Regional Deep Dive\n<\/p>\n<p>\n11.1.1 North America\n<\/p>\n<p>\n11.1.2 Europe\n<\/p>\n<p>\n11.1.3 Asia-Pacific\n<\/p>\n<p>\n11.1.4 ROW\n<\/p>\n<p>\n<strong>CHAPTER 012 Trends, Drivers, and Challenges<\/strong>\n<\/p>\n<p>\n12.1 Regenerative Medicine in Pharma &#8211; Market Trends\n<\/p>\n<p>\n12.1.1 Constant Innovation in Cell Engineering Techniques:\n<\/p>\n<p>\n12.1.2 Increasing Application of Gene Therapy:\n<\/p>\n<p>\n12.1.3 Fast Track Approvals and Multiple Drugs in Last Stages of Pipeline\n<\/p>\n<p>\n12.1.4 the Momentum Created by Allogenic Therapeutics Continues to Drive Market:\n<\/p>\n<p>\n12.1.5 Increasing Applications of 3D Printing in Regenerative Medicine:\n<\/p>\n<p>\n12.2 Regenerative Medicine in Pharma &#8211; Market Drivers\n<\/p>\n<p>\n12.2.1 Growing Prevalence of Chronic Diseases, Genetic Disorders, and Cancer\n<\/p>\n<p>\n12.2.2 Technological Advancements in Stem-Cell Therapies\n<\/p>\n<p>\n12.2.3 Increased Investment by Key Players in R&amp;D of the Regenerative Medicines\n<\/p>\n<p>\n12.3 Regenerative Medicine in Pharma &#8211; Market Challenges\n<\/p>\n<p>\n12.3.1 Gene Therapy\n<\/p>\n<p>\n12.3.2 Cell Therapy\n<\/p>\n<p>\n12.3.3 Tissue-Engineered Products and Biomaterials\n<\/p>\n<p>\n<strong>CHAPTER 013 Regenerative Medicine in Pharma Market Vendor Snapshot<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 014 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nNovartis\n<\/li>\n<li>\nGilead\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nBristol Myers-Squibb\n<\/li>\n<li>\nBluebird bio\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nBiomarin\n<\/li>\n<li>\nPTC Therapeutics\n<\/li>\n<li>\nOrchard Therapeutics\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5699683\/regenerative-medicine-in-pharma-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=ps3hgj&amp;utm_campaign=1791793+-+Regenerative+Medicine+in+Pharma+Market+to+Grow+by+11.1%25++Annually+Through+2027+&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/47qzh8<\/a>\n<\/p>\n<p>\nSource: GlobalData\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#115;&#64;&#114;&#101;&#115;&#101;&#97;rchand&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pres&#115;&#64;&#114;&#101;&#115;&#101;&#97;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;kets&#46;&#99;&#111;&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52115","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-19T11:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-19T11:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/\"},\"wordCount\":800,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005338\\\/en\\\/1668398\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/\",\"name\":\"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005338\\\/en\\\/1668398\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-19T11:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005338\\\/en\\\/1668398\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005338\\\/en\\\/1668398\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-19T11:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 &#8211; ResearchAndMarkets.com","datePublished":"2022-12-19T11:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/"},"wordCount":800,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/","name":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg","datePublished":"2022-12-19T11:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221219005338\/en\/1668398\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-in-pharma-market-to-grow-by-11-1-annually-through-2027-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Regenerative Medicine in Pharma Market to Grow by 11.1% Annually Through 2027 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52115"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52115\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}